Vivani Medical, Inc. Announces Pricing of Common Stock Offering
October 26, 2025 19:15 ET | Source: Vivani Medical, Inc. ALAMEDA, Calif.,…
Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025
GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ -- India's 1st indigenously designed and…
Xinhua Silk Road: China’s Langjiu holds “Chinese Langjiu, Welcoming the World” event in Italy
BEIJING, Oct. 27, 2025 /PRNewswire/ -- Langjiu, a leading Chinese baijiu brand,…
Credit Blockchain Brings AI Computing to the Forefront, Targeting Stability Amid Crypto Turbulence
London, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Credit Blockchain, a global leader…
Hohem Lands in Best Buy Stores with AI Gimbals
NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Hohem, a global leader…
New Crypto Mutuum Finance (MUTM) Announces V1 Protocol as Investor Count Tops 17,400
Dubai, UAE, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Ethereum remains at the…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
CGTN: Restoring the History of Taiwan
BEIJING, Oct. 25, 2025 /PRNewswire/ -- Men forget, and history overlooks. But…
